Burgel, Pierre-Régis http://orcid.org/0000-0003-0903-9828
Laurendeau, Caroline
Raherison, Chantal
Fuhrman, Claire
Roche, Nicolas
Funding for this research was provided by:
Nycomed France
Cardif Association
Article History
Received: 1 May 2018
Accepted: 8 June 2018
First Online: 27 June 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: PRB reports personal fees from Astra-Zeneca, personal fees from Boehringer Ingelheim, personal fees from Chiesi, personal fees from GSK, personal fees from Novartis, personal fees from Pfizer, personal fees from TEVA/Aptalis, personal fees from Vertex, personal fees from Zambon outside the submitted work. CL reports grants from AERE during the conduct of the study; grants from GSK, grants from Boehringer Ingelheim outside the submitted work. CR reports personal fees from Astra Zeneca, personal fees from Boeringher Ingelheim, personal fees from Chiesi, personal fees from GSK, personal fees from Novartis, personal fees from ALK, personal fees from Mundipharma, from TEVA outside the submitted work. CF has no competing interest. NR reports personal fees from Chiesi, during the conduct of the study; grants and personal fees from Boehringer Ingelheim, grants and personal fees from Novartis, personal fees from Teva, personal fees from GSK, personal fees from AstraZeneca, personal fees from Chiesi, personal fees from Mundipharma, personal fees from Cipla, grants and personal fees from Pfizer, personal fees from Sanofi, personal fees from Sandoz, personal fees from 3 M, personal fees from Zambon, outside the submitted work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.